Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palifermin for Acute GVHD Reduction
NCT00189488Phase 2Completed
- Sponsor
- Sobi
- Start
- Dec 2005
- Primary completion
- Nov 2008
- Modality
- Cytokines & Interferons
01
Overview
A Phase 2 trial of palifermin in graft-versus-host disease (GVHD), oral mucositis (OM), sponsored by Sobi. Started Dec 2005; status: completed.
02
Drugs
palifermin
03
Conditions
graft-versus-host disease (GVHD)oral mucositis (OM)
Beyond the preview
Go deeper on NCT00189488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189488.